SUNG-WON LEE: Open Payments
NPI 1144296492 · PALISADES PARK, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,468 in 76 payments from 16 companies in 2025. Trend: 2023 $1,271 · 2024 $1,076 · 2025 $1,468
Food & beverage: $1,468
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $303 |
| Amgen Inc. | 15 | $238 |
| SCILEX PHARMACEUTICALS INC. | 11 | $151 |
| AstraZeneca Pharmaceuticals LP | 8 | $125 |
| Exact Sciences Corporation | 5 | $106 |
| Novo Nordisk Inc | 6 | $88 |
| Aimmune Therapeutics, Inc. | 5 | $84 |
| PFIZER INC. | 4 | $65 |
| Dexcom, Inc. | 3 | $64 |
| GlaxoSmithKline, LLC. | 3 | $56 |
Products named: JARDIANCE, OTEZLA, ZTLido, ZENPEP, FARXIGA, Dexcom G6 Transmitter, The Cologuard Plus Collection Kit, SHINGRIX.
Industry payments across NJ — which companies pay providers there.
